| Jun 16 |
Incyte: The Worst Has Been Avoided
|
| Jun 14 |
Insider Sale: EVP & General Manager US Barry Flannelly Sells 19,164 Shares of Incyte Corp (INCY)
|
| Jun 13 |
Incyte Announces Final Results of Tender Offer
|
| Jun 11 |
Incyte tenders ~29.8M shares at $60.00 per share
|
| Jun 11 |
Incyte Announces Preliminary Results of Tender Offer
|
| Jun 7 |
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Jun 6 |
Agilent (A) Boosts Reach to Lab Researchers With New Devices
|
| Jun 6 |
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
|
| Jun 6 |
We Think Shareholders Are Less Likely To Approve A Pay Rise For Incyte Corporation's (NASDAQ:INCY) CEO For Now
|
| May 31 |
Sarepta Therapeutics (SRPT) Down 4.7% Since Last Earnings Report: Can It Rebound?
|
